Baxter International vs Glaukos
Baxter International (BAX), health care, and Glaukos (GKOS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Glaukos is worth $14.4B on the stock market and Baxter International $13.3B: Glaukos is valued at 8% more. Baxter International's operating margin in its latest fiscal year was -2.74% and Glaukos's -39.3%. Over the past year Baxter International's share price has moved +40.7% and Glaukos's +167%.
Key facts
- Baxter International market value
- $13.3B
- Glaukos market value
- $14.4B
- Baxter International revenue
- $11.2BFY to 2025-12-31
- Glaukos revenue
- $507.4MFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Baxter International | Glaukos |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $13.3Blower | $14.4Bhigher |
| Revenue | $11.2Bhigher | $507.4Mlower |
| Earnings | -$957Mlower | -$187.7Mhigher |
| Employees | 37,500higher | 1,094lower |
| Total assets | $20.1Bhigher | $893.5Mlower |
| Valuation | ||
| P/E | — | — |
| P/S | 1.2lower | 28.4higher |
| P/B | 2.0lower | 20.1higher |
| Dividend yield | 0.16%higher | 0.00%lower |
| Profitability | ||
| Operating margin | -2.74%higher | -39.3%lower |
| Balance sheet | ||
| Net assets | $6.1Bhigher | $656.2Mlower |
| Total liabilities | $14Bhigher | $237.3Mlower |
| Total debt | $9.5B | — |
| Cash on hand | $2Bhigher | $90.8Mlower |
| Price change | ||
| Today | +0.86%higher | -0.67%lower |
| 1 year | +40.7%lower | +167%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Baxter International only (6)
- Richard Pzena4.4%
- Edgar Wachenheim3.7%
- Steven Romick2.2%
- Dodge & Cox team0.7%
- Boaz Weinstein0.1%
- Tweedy, Browne team<0.1%
Glaukos only (4)
- Brandon Haley0.5%
- Primecap team0.3%
- Israel Englander0.1%
- Polen Capital team0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns BAX · Who owns GKOS
More on Baxter International
Further comparisons
Baxter International against its closest peers
Glaukos against its closest peers
Learn
Questions and answers
Which is bigger, Baxter International or Glaukos?
By market value, Glaukos is the larger: $14.4B against $13.3B for Baxter International. By revenue in its latest fiscal year, Baxter International is the larger: $11.2B against $507.4M for Glaukos.
Which has the higher operating margin?
Baxter International: -2.74%, against -39.3% for Glaukos. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Baxter International: 0.16%, against 0.00% for Glaukos. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Baxter International and Glaukos?
None of the tracked superinvestors holds both in their latest 13F filing. 6 hold Baxter International and 4 hold Glaukos.
Cite this page
Funkfolio, “Baxter International vs Glaukos”, data as of 18 November 2026. https://funkfolio.com/compare/bax-vs-gkos
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.